I will be talking on the Factor Investing panel at the upcoming Evidence-Based Investing Conference in Dana Point, CA next Sunday –Tuesday. I am excited for the opportunity to chat and figured I would highlight a few thoughts we have on the topic going into the event. First, what is “evidence based investing?” What does that even mean? If we read a index factsheet, review a long-term live track record, or read an academic finance paper, are we now an evidence-based investor? No. To me, evidence based investing means reviewing all the relevant research on a topic, viewing this body of research as a whole, understanding the economic/human underpinnings of the finding, and then making an informed decision that is as objective as possible. Achieving the title of being an “evidence based investor” sounds easy, but the reality is that this is incredibly difficult. This difficulty is only magnified by the sheer amount of information and (so-called) research being distributed into the marketplace. To solve this information overload problem investors often get complacent and rely on a single firm’s research (or research group) to inform their opinion on all matters. This approach will likely turn you into a faith based investor, not an evidence based investor (see here for a piece on the subject). And when it comes to factor investing, we often see well-meaning investors, who want to be evidence-based investors, quickly devolving into faith based investors who are no longer critically reviewing and assessing the available research. With factor investing there are a few topics worth discussing:
- Factor Premiums — Are they here to stay?
- Factor Portfolio Construction – Does it matter?
- Factor Investing Funds – What are you actually buying?
Factor Investing Premiums – Are they here to stay?Are factor premiums here to stay or have they been arbitraged away? This is a common question we are asked. As advocates of factor-investing 1, how does one respond to the countless articles citing the evidence that factor/active funds are losing to the passive index? Our response is not satisfying: active (factor) investing is simple, but not easy. As we have highlighted in the past (I recommend you read the entire article), active factor portfolios are notoriously challenging for investors. Consider value investing, the most well-known factor approach. Value investing has had numerous periods of underperformance, especially during the Internet Bubble. Using Ken French’s data, we examined just how painful it was to be a value investor in the late ’90s. We examine the returns from 1/1/1994-12/31/1999 for a Value portfolio (High B/M quintile, VW returns), Growth portfolio (Low B/M quintile, VW returns), Risk-Free return (90-day T-Bills), and SP500 total return. Results are shown in Figure 1 below. All returns are total returns and include the reinvestment of distributions (e.g., dividends). Results are gross of fees. 2
Figure 1: Summary Statistics (1994-1999)Talk about a bad stretch! Looking at the annual returns (shown in Figure 2), value investing lost almost every year to the market!
Figure 2: Annual ReturnsWhat would their hypothetical returns look like in the long run? As you can see below in Figure 3, value quickly recovers and outperforms the entire time period thereafter. Here are the returns to the same portfolios from 1/1/2000 – 12/31/2014, the 15 years following the 5-year underperformance:
Figure 3: Summary Statistics (2000-2014)Sticking with the value strategy, although painful, was richly rewarded with a 4.67%+ edge–per year–over the market benchmark from 2000-2014. Over the entire cycle, patient, disciplined investors were also rewarded. Here are the results (Figure 4) over the entire time period, measured from 1/1/1994 to 12/31/2014:
Figure 4: Summary Statistics (1994-2014)Similarly, here is a more recent example using momentum. A common argument is that there are too many supercomputers / Ph.D.s / CFAs in the market so momentum investing is dead. For example, here is a chart on the performance of momentum over the past several decades: 3 The chart certainly follows along with the story — but correlation is not causation. Here is a chart extended back to 1801, which shows that decade-long periods of poor relative performance are not uncommon. If we subscribe to the theory that better technology, smarter people, and more competition are associated with arbitraging away the momentum factor premium, we also need to then potentially explain why momentum went on a 10-year drought following the Civil War. Were the momentum premiums arbitraged away? Perhaps these premiums are simply riskier. So witnessing long absolute (and relative) performance droughts, is a feature — not a bug — of momentum investing. If higher risk is a feature of factor strategies they should command long-term expected return premiums — otherwise, why would anyone take the other side of the trade! In short, factor investing strategies need to be painful in order to be sustainable. If factor strategies represent $20 dollar bills lying on the street, one can be sure they will vanish almost immediately and never be seen again. Let’s summarize. Any active factor investor should expect the following (in the short-run):
- They will lose to the market with a 100% probability over some time period.
- They will experience a multi-year relative performance drought.
Factor Investing – Does portfolio construction matter?We can argue about factor investing in the future, and what the premiums might look like over the long haul. These are important discussions. To inform our opinion on these debates we can infuse it with some data from the past. Investors are lucky nowadays because they can lean on the backs of thousands of Ph.D. students grinding on the stock databases. Here is a link to one (of many) papers highlighting all the anomalies in the literature (here is a replication paper). A few factors tend to pop out from the literature and from our own research – Value, Momentum, Low Volatility, Quality, and Size. These factors all exhibited a “premium” over the value-weight market portfolio in the past. In general, these factors appear to be the most robust, but none of them are perfect (arguably why they exist). One missing component from the factor debate is related to portfolio construction. Academic papers often analyze zero-investment long/short portfolios which are impossible to implement in the real world. We investigated. I decided to test what were the returns to long-only Value and Momentum portfolios when one varies the number of firms in the portfolio, as well as the holding period (how often the portfolio is refreshed). The basic idea is the following – every month take the top 1,000 firms based on market capitalization. Then select the top 50, 100, 150, etc. firms based on either a Value measure (EBIT/TEV) 9 or a Momentum measure (12_2 momentum). 10 In addition to varying the number of firms in the portfolio, I also wanted to vary the holding period. In my tests, I allow the holding period to vary from one up to twelve months. 11 I have updated the results, which now run from 1970 – 2016. All returns are to value-weight portfolios 12 and are gross of any transaction costs or fees. 13 Value Portfolios (1970 – 2016) Momentum portfolios (1970 – 2016). Now to be clear, the results shown above are before any management fees or transaction costs. 14 We allow the reader to judge an appropriate transaction cost to apply, as many argue over this number (see here and here). However, if one assumes 0.25% per rebalance, the results are pretty clear for Value and Momentum – in the past, portfolios with more concentration (less stocks) and more frequent rebalancing (such as quarterly), outperformed a larger-stock portfolio that is only rebalanced once a year. As long-term investors looking to capture the largest equity risk premiums should we all switch to concentrated Value and Momentum portfolios that are rebalanced more than one a year? No. But why not? Because the career risk and psychological pain may be too great. One way to measure this risk is via tracking error, which is essentially the standard deviation of the difference between a particular strategy and the benchmark (in this case the SP500). 15 The tracking errors numbers for the various factor portfolios are below: Value Portfolio Tracking Error (1970 – 2016) Momentum Portfolio Tracking Error (1970 – 2016) Most investors like to track the broad market indices. However, one thing is clear from the charts above — a strong positive relationship between factor returns and tracking error. In short, if you want more expected returns, you need to embrace the risks associated with tracking error. This finding has implications for a variety of investors. Consider an independent financial advisor building a portfolio on behalf of a client. Part of the advisor’s job is to understand the client’s goals as well as the client’s mindset when it comes to investing. If the advisor believes the client is going to ask every quarter (or every year) how they did relative to the index, and if they underperformed they will quit the strategy. In this case, it is probably not a great idea to invest in concentrated factor portfolios. Perhaps the advisor sprinkles in a small dosage of concentrated Value or Momentum (5% or less) alongside a bunch of cheap beta? Maybe they go for a more diluted version of Value and Momentum with less tracking error and put 50% in the “smart beta” form of the factor and 50% in cheap beta? An evidence based investor should make portfolio decisions based both on the knowledge of the (1) portfolio construction and (2) the mindset of the investor.
Factor Investing – What am I buying?Now let’s assume we’ve read all the academic research on factor portfolios and factor premiums. We know factor investing is –and has to be — painful at times. We know factor investing portfolio construction has effects on determining the expected excess returns. Now let’s turn to the market to purchase a smart-beta factor portfolio that incorporates all the knowledge we have on our plate. Unfortunately, this can be harder than anticipated. Investors are faced with a serious challenge these days. Even if you have a PhD in finance, it can be hard to identify what you are buying based on the marketing materials and analytical tools available in the market. That said, one way an investor can identify what a portfolio delivers to an investor is to examine the portfolio factor loadings over time (a DFA favorite). However, factor models can be finicky, and changing how one defines the factors (e.g., the definition of the “Value,” or HML factor) can have massive impacts on the conclusions one makes. Another approach is to understand how a portfolio is formed (e.g., construction analysis above), and how this will drive portfolio characteristics (e.g., B/M of .5 versus 2), which will arguably be more predictive of expected excess returns than the factor loading. (see here for some research on the topic). This approach is useful, and we highlight the results above, but this approach is also unrealistic for the typical investor unless they are extremely sophisticated and can program. Another tool (aside from tracking error) is to examine the “active share” of the portfolio to determine how different the factor-investing fund is from the market-cap weighted index. 16 Active share calculations are hard to come by and this measure is not perfect, as being highly active does not necessarily imply outperformance. One still needs to understand the characteristics of the portfolio. For example, one can purchase a high active share overpriced growth stock portfolio, but it is unclear whether or not a long-term factor investor wants a high active share bet on what has historically been a long-term loser factor. We’ve even attempted to create our own tools to help investors make better decisions. We call it visual active share (were developing this further over the summer). The mission of visual active share is to create a 1) simple, 2) intuitive, and 3) powerful way for investors to understand what they are buying. Currently, the tool allows investors to select (U.S. based equity) ETFs and view the underlying holdings, where the holdings are ranked on a laundry list of common factor characteristics, such as market-cap, Book-to-Market, Momentum, etc. We also include “fake” academic anomaly portfolios which more closely reflect how anomaly portfolios are created in academic literature which documents these factor premiums. 17 For example, the B/M effect may be characterized by sorting the universe of stocks on the 10% cheapest set of firms on B/M, rebalanced annually, and comparing this to other portfolios (the 10% most expensive firms) to determine if the factor portfolios is “anomalous.” To see how the academic portfolios work, start typing “academic” in the “add ETFs” box of our tool. Let’s stick with the classic value measure in academic literature — price-to-book. We type in “PB_BTM” or “academic bottom decile P/B.” Out pops a portfolio. We percentile rank the underlying firms along the x-axis on the Price-to-Book measure (inverse of book-to-market) and along the y-axis on market capitalization. As one can see, the academic portfolio (not an actual ETF) buys the cheapest 20% of stocks based on price to book (we eliminate micro-caps). Now let’s select the SPY ETF, which invests in the SP500 stocks. As one can see, SPY is a large-cap fund with little deference to value or growth characteristics (as defined by P/B). Let’s say we want a little value exposure. We pick a Value ETF, the Vanguard S&P 500 Value ETF (VOOV). We plot it out on visual active share: From the images above, one can see that the Vanguard Value ETF is nothing like the academic factor portfolio, which arguably captures the factor premium as it is documented in academic research. So what are we buying? As the picture highlights, we’re buying a portfolio very similar to the S&P 500 exposure. 18 Now to be clear, I am not picking on Vanguard here – I believe they are a great institution that has done more for investors than any other financial institution in the last 40 years. And to be fair, their Value portfolio uses numerous value measures, so they shouldn’t exactly line up with the academic portfolio. Second, they are Vanguard – they are taking in billions of dollars a day, so they need to invest in larger stocks that have enough liquidity. By construction, they almost have to be close to the S&P 500. However, I think most would agree that their portfolio is not capturing the risk/rewards of the academic value portfolio. So to the extent that an investor wants to capture the academically documented factors (such as Value and Momentum) in unique and differentiated ways, our tool will help to assess ETFs currently available in the marketplace.
ConclusionI covered a few topics pertinent to factor investing. First, will factor investing premiums be here in the future? I believe they will exist due to investor behavior, but I could be wrong. In the future, if the headlines state that “investors plow record amounts into vastly under-performing Value funds” – I may be worried. However, people generally chase performance, and the same goes for factors. Second, portfolio construction mattered in the past – it is something an evidence-based investor should understand. Third, assessing real-world portfolios can be difficult, so we are trying to help build tools to help the investing public. I look forward to the factor investing panel at the evidence based investing conference next week. If you are going to be there and want to meet up, please let me know!
- which is a form of active investing, just done in a systematic fashion ↩
- CAGR: Compound annual growth rate
- Standard Deviation: Sample standard deviation
- Downside Deviation: Sample standard deviation, but only monthly observations below 41.67bps (5%/12) are included in the calculation
- Sharpe Ratio (annualized): Average monthly return minus treasury bills divided by standard deviation
- Sortino Ratio (annualized): Average monthly return minus treasury bills divided by downside deviation
- Worst Drawdown: Worst peak to trough performance (measured based on monthly returns) ↩
- Two Centuries of Price Return Momentum by Chris Geczy and Mikhail Samonov. ↩
- Of course, the factor investing portfolio may win, but it is not guaranteed ↩
- Example being LSV 1994 ↩
- Fama and French ↩
- I wish I had this knowledge! ↩
- There are some factor premiums that can be argued will go away due to lower limits to arbitrage. I am focusing on Value and Momentum which do not fall into that category ↩
- See our paper examining all the Value factors here, and the updated data here. ↩
- The 12_2 momentum measures the total return to a stock over the past year ignoring the last month ↩
- Note for any holding period over one month, overlapping portfolios are used. ↩
- Equal-weight portfolios yield similar results ↩
- Note the Universe returns are slightly different due to the Value portfolios requiring fundamental information that Momentum portfolios don’t require. ↩
- Transaction costs were much larger in the past then they were today. We discuss competing research on momentum transaction costs here, here, and here. ↩
- Here and here are some primers on the concept. ↩
- Here is a tool by Professor Marijn Cremers. We also have a tool on our website. ↩
- You can read more about this here. ↩
- Something that sits to the bottom right of the charts in the prior section on portfolio construction ↩